This page shows the latest VJOncology news and features for those working in and with pharma, biotech and healthcare.
The results of the Phase III KEYNOTE-024 trial of pembrolizumab for non-small cell lung cancer (NSCLC) were presented by VJOncology Editorial Board Member Dr Martin Reck of LungenClinic Grosshansdorf.
Brandcast is a commercial and video publishing partner for VJHemOnc and VJOncology.
More from PMHub
Approximately 1 fully matching, plus 1 partially matching documents found.
AMICULUM® is an independent global healthcare communications, consulting and learning business with a global team of >220 healthcare communications professionals,...